Castilia Life Sciences Private Limited
About Castilia Life Sciences Private Limited
Data last updated:
Castilia Life Sciences Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the pharmaceutical chemical segment of the chemicals sector. It was incorporated on 08 December 2005.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH2005PTC157904.
The company had an authorised share capital of ₹1.11 Cr and a paid-up capital of ₹13.21 Lakh. It was led by directors Sugandha Jaidev Hiremath and Jai Vishwanath Hiremath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at 1203 Maker Chamber V221 Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹39,944, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹23,013 (net margin 57.6%) and EBITDA of ₹23,013 (EBITDA margin 57.6%). Revenue has grown at a compounded annual rate (CAGR) of 195% over three years and 36% over five years.
Company details
Contact details
Castilia Life Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1203 Maker Chamber V221 Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryChemicals, Pharmaceutical Chemical, Other Chemical Product, Manufacturing
To see the full contact details of Castilia Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Castilia Life Sciences Private Limited
FY 2025 filings availableCastilia Life Sciences Private Limited reported revenue of ₹39,944 (up 903% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 903% growth in the latest year. EBITDA rose 156% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23,013 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23,013 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 57.6% | ||||
| Net Profit Margin | 57.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Castilia Life Sciences Private Limited, buy the company report.
Board of directors of Castilia Life Sciences Private Limited
Castilia Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sugandha Jaidev Hiremath | Director | 08 Mar 2007 | 19 Years 7 Months | As last reported |
| Jai Vishwanath Hiremath Also directs: Castilia Life Sciences LLP, Hikal Limited, Rushabh Capital Services Private Limited and 3 more | Director | 13 May 2025 | 1 Years 5 Months | As last reported |
Peer comparison
Castilia Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Winsome Laboratories Limited | ₹41,916 (FY 2025) | 5.0% | Delhi, India | |||
| Harson Labs Pvt Ltd | ₹41,378 (FY 2025) | -98.0% | Vadodara, Gujarat, India | |||
| Vyome Biosciences Private Limited | ₹40,161 (FY 2025) | -96.0% | Vadodara, Gujarat, India | |||
| Allhazen Humancare Private Limited | ₹40,125 (FY 2024) | 98.0% | Lucknow, Uttar Pradesh, India | |||
| Nirlabs Welson Pharmaceutical India Private Limited | ₹40,025 (FY 2025) | -91.0% | Lucknow, Uttar Pradesh, India | |||
| Castilia Life Sciences Private Limitedthis company | ₹39,944 (FY 2025) | ₹23,013 | 57.6% | 903.0% | Mumbai, Maharashtra, India | |
| Mirallex Remedies Private Limited | ₹39,800 (FY 2025) | Washim, Maharashtra, India | ||||
| Hoffen Remedies Private Limited | ₹39,229 (FY 2024) | -14.0% | Kanpur, Uttar Pradesh, India | |||
| Panashe Industries Private Limited | ₹39,039 (FY 2024) | -58.0% | New Delhi, Delhi, India | |||
| Aween Pharmaceuticals Private Limited | ₹38,500 (FY 2019) | Narayanpur, Bihar, India | ||||
| Tystart Facility Private Limited | ₹37,212 (FY 2025) | -98.0% | Dadri, Uttar Pradesh, India |
To see the full peer comparison of Castilia Life Sciences Private Limited, buy the company report.
Auditor
Castilia Life Sciences Private Limited is audited by R. P. SARDAR & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. P. SARDAR & CO. | FY 2017 | 037845 |
Shareholding
The shareholding of Castilia Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Castilia Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Castilia Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Castilia Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Castilia Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Castilia Life Sciences Private Limited has 5 board changes on record since 2007: 2 appointments and 3 cessations. The latest: Jai Vishwanath Hiremath ceased to be Additional Director on 29 Sep 2025.
Frequently asked questions
Castilia Life Sciences has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Castilia Life Sciences was a private limited company based in Mumbai, Maharashtra, India. The company worked in pharmaceutical chemical, within the chemicals industry. It was incorporated on 08 December 2005 and is registered under CIN U24231MH2005PTC157904. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Castilia Life Sciences is U24231MH2005PTC157904. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Castilia Life Sciences had 2 directors:
- Sugandha Jaidev Hiremath - Director
- Jai Vishwanath Hiremath - Director
Castilia Life Sciences was incorporated on 08 December 2005. It is registered with the Registrar of Companies, Mumbai.
The registered office of Castilia Life Sciences is at 1203 Maker Chamber V221 Nariman Point, Mumbai, Maharashtra, India – 400021.
The latest financial statements of Castilia Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
Castilia Life Sciences operated in the chemicals industry, in the pharmaceutical chemical segment.
The peers of Castilia Life Sciences by revenue are Winsome Laboratories Limited, Harson Labs Pvt Ltd, Vyome Biosciences Private Limited, Allhazen Humancare Private Limited, Nirlabs Welson Pharmaceutical India Private Limited and 5 more, all in the Pharma industry (Formulations).
Jai Vishwanath Hiremath ceased to be Additional Director on 29 Sep 2025. Anish Dilip Swadi ceased to be Director on 10 Jun 2025. Pallavi Swadi Anish ceased to be Director on 10 Jun 2025. Castilia Life Sciences has 5 board changes on record in total.
The compliance status of Castilia Life Sciences is compliant as of 05 July 2026.